MMP-9

MMP-9 詳細

英語名Matrix metalloproteinase 9市販薬剤の数0
治験薬の数3ターゲットの別称Type V Collagenase,Gelatinase B,EC 3.4.24.35,MANDP2,Matrix Metalloproteinase 9,CLG4B,MMP9,Matrix Metallopeptidase 9,Matrix Metalloproteinase 9 (Gelatinase B, 92kDa Gelatinase, 92kDa Type IV Collagenase),GELB,Matrix Metalloproteinase-9,92 KDa Type IV Collagenase,Macrophage Gelatinase,92 kDa gelatinase,MMP-9,Matrix Metallopeptidase 9 (Gelatinase B, 92kDa Gelatinase, 92kDa Type IV Collagenase),EC:3.4.24.35,EC 3.4.24
研究&開発段階Phase 3 Clinical
英語名Matrix metalloproteinase 9
ターゲットの別称Type V Collagenase,Gelatinase B,EC 3.4.24.35,MANDP2,Matrix Metalloproteinase 9,CLG4B,MMP9,Matrix Metallopeptidase 9,Matrix Metalloproteinase 9 (Gelatinase B, 92kDa Gelatinase, 92kDa Type IV Collagenase),GELB,Matrix Metalloproteinase-9,92 KDa Type IV Collagenase,Macrophage Gelatinase,92 kDa gelatinase,MMP-9,Matrix Metallopeptidase 9 (Gelatinase B, 92kDa Gelatinase, 92kDa Type IV Collagenase),EC:3.4.24.35,EC 3.4.24
市販薬剤の数0
治験薬の数3
研究&開発段階Phase 3 Clinical

MMP-9 製品リスト

  • 属性

    Protein (6)

  • 製品ライブラリ

    オンライン (6)

  • Human (4)Mouse (1)Cynomolgus (1)

  • タグ

    His Tag (6)

  • マーカー

    Unconjugated (6)

MMP-9バックグランド

Matrix metallopeptidase 9 (MMP-9) is also known as 92 kDa type IV collagenase, 92 kDa gelatinase or gelatinase B (GELB), CLG4B, is secreted from neutrophils, macrophages, and a number of transformed cells, and is the most complex family member in terms of domain structure and regulation of its activity. . Structurally, MMP9 maybe be divided into five distinct domains: a prodomain which is cleaved upon activation, a gelatinbinding domain consisting of three contiguous fibronectin type II units, a catalytic domain containing the zinc binding site, a prolinerich linker region, and a carboxyl terminal hemopexinlike domain. This enzyme degrades various substrates including gelatin, collagen types IV and V, and elastin. MMP9 is involved in a variety of autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis, and multiple sclerosis, and be regarded as a potential therapeutic target.

MMP-9分子の別称

MMP9,CLG4B,GELB,MANDP2,Gelatinase B

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
AndecaliximabGS-5745Phase 3 ClinicalGilead IncArthritis, Rheumatoid; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colitis, Ulcerative; Colorectal Neoplasms; Crohn Disease; Cystic Fibrosis; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Myositis Ossificans; Ossification, Heterotopic; Pancreatic Neoplasms; Pulmonary Disease, Chronic Obstructive; Spinal Cord Injuries; Stomach Neoplasms
詳細
AQU-005AQU-005; NMAQU-005; NM-AQU-005Phase 1 ClinicalAquilus PharmaceuticalsNeuralgia
詳細
CALY-001CALY-001ClinicalCalypso Biotech BvCrohn Disease; Inflammatory Bowel Diseases
詳細
  • 詳細
  • 製品リスト
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8